Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KNC Laboratories CoFRA:7LW -2.02%81 Pretax Margin % is 17.78% as of Mar. 2026, which is 29% above its 10-year median of 13.74. GuruFocus rates FRA:7LW with a GF Score™ of 81/100 and a GF Value™ of €6.31. The stock has 9 warning signs investors should review. Among 1,578 Chemicals companies, KNC Laboratories Co ranks better than 71.55% on this metric.
The historical rank and industry rank for KNC Laboratories Co's Pretax Margin % or its related term are showing as below:
FRA:7LW'
s Pretax Margin % Range Over the Past 10 Years
Min: 9.72 Med: 13.74 Max: 25.18
Current: 11.28
FRA:7LW's Pretax Margin % is ranked better than 71.55% of 1578
companies
in the Chemicals industry
Industry Median: 5.35
vs FRA:7LW: 11.28
KNC Laboratories Co (FRA:7LW) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
KNC Laboratories Co Pretax Margin % Related Terms
KNC Laboratories Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for KNC Laboratories Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, KNC Laboratories Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KNC Laboratories Co Pretax Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, KNC Laboratories Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where KNC Laboratories Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNC Laboratories Co (FRA:7LW) has a Pretax Margin % of 17.78% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on KNC Laboratories Co and its competitors. This is 29% above median its historical median of 13.74. Over the past decade, KNC Laboratories Co's Pretax Margin % has ranged from 9.72 to 25.18. According to the industry distribution chart, KNC Laboratories Co ranks #449 out of 1578 companies in the Chemicals industry, placing it in the top 28.5%.
Is KNC Laboratories Co's Pretax Margin % too high?
KNC Laboratories Co's current Pretax Margin % of 17.78% is 29% above median its 10-year median of 13.74. Over the past 10 years, this metric has ranged from a low of 9.72 to a high of 25.18. The Chemicals industry median Pretax Margin % is 5.35. KNC Laboratories Co's value of 17.78% is 232.3% above this industry median. Based on the distribution chart, KNC Laboratories Co ranks #449 out of 1578 companies in the Chemicals industry, which is above the industry midpoint. Overall, KNC Laboratories Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's Pretax Margin % compare to DOW?
According to the Chemicals industry distribution chart, KNC Laboratories Co ranks #449 out of 1578 companies for Pretax Margin %. This puts KNC Laboratories Co in the upper half of its industry. The industry median Pretax Margin % is 5.35. KNC Laboratories Co's value of 17.78% is 232.3% above this benchmark. Historically, KNC Laboratories Co's own Pretax Margin % has ranged from 9.72 to 25.18 over the past decade. While the company's 10-year median is 13.74 vs. the industry median of 5.35, KNC Laboratories Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Chemicals company?
The median Pretax Margin % among Chemicals companies is 5.35, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KNC Laboratories Co's current Pretax Margin % of 17.78% is 232.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on KNC Laboratories Co and its competitors. For the Chemicals industry, the median Pretax Margin % is 5.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KNC Laboratories Co's current Pretax Margin % is 17.78%, which is 29% above median its own 10-year median of 13.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
KNC Laboratories Co (FRA:7LW) has a current Pretax Margin % of 17.78%. The stock's GF Value™ is €6.31, compared to a current price of €6.30 — trading 0.2% below its estimated fair value. The current Pretax Margin % is 17.78%, which is 29% above median its 10-year median of 13.74 and 232.3% above the Chemicals industry median of 5.35. KNC Laboratories Co's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For KNC Laboratories Co (FRA:7LW), the current Pretax Margin % is 17.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KNC Laboratories Co (FRA:7LW) Overvalued in 2026?
Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be undervalued.
The current stock price of €6.30 is trading 0.2% below its estimated GF Value™ of €6.31.
Key valuation signals for FRA:7LW:
Pretax Margin %: 17.78% (29% above median its 10-year median of 13.74)
GF Value™: €6.31 vs. price of €6.30 (0.2% below fair value)
Industry Position: 232.3% above the Chemicals median (#449 of 1578)
No single metric tells the full story. See the FRA:7LW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7LW has been successfully added to your 
